During the past decade, AZ Sint-Lucas conducted 31 clinical trials. In the 10-year time frame, 31 clinical trials started and 13 clinical trials were completed, i.e. on average, 41.9% percent of trials that started reached the finish line to date. In the past 5 years, 12 clinical trials started and 7 clinical trials were completed. i.e. 58.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "AZ Sint-Lucas" #1 sponsor was "Allergan" with 4 trials, followed by "Hoffmann-La Roche" with 4 trials sponsored, "KU Leuven" with 3 trials sponsored, "Abivax S.A." with 2 trials sponsored and "Celgene" with 2 trials sponsored. Other sponsors include 22 different institutions and companies that sponsored additional 29 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "AZ Sint-Lucas" #1 collaborator was "Kom Op Tegen Kanker" with 3 trials as a collaborator, "AZ Sint-Lucas Brugge" with 2 trials as a collaborator, "Jessa Hospital" with 2 trials as a collaborator, "Universitair Ziekenhuis Brussel" with 2 trials as a collaborator and "Ziekenhuis Oost-Limburg" with 2 trials as a collaborator. Other collaborators include 29 different institutions and companies that were collaborators in the rest 39 trials.

According to Clinical.Site data, the most researched conditions in "AZ Sint-Lucas" are "Eosinophilic Esophagitis" (4 trials), "Gastroparesis" (4 trials), "Diabetes Mellitus" (3 trials), "Ulcerative Colitis" (3 trials) and "Colorectal Cancer" (2 trials). Many other conditions were trialed in "AZ Sint-Lucas" in a lesser frequency.

Most popular intervention types in "AZ Sint-Lucas" are "Drug" (31 trials), "Other" (4 trials), "Biological" (2 trials), "Device" (2 trials) and "Procedure" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (13 trials), "Bevacizumab" (3 trials), "Relamorelin" (3 trials), "CC-93538" (2 trials) and "Carboplatin" (2 trials). Other intervention names were less common.

The vast majority of trials in "AZ Sint-Lucas" are 37 trials for "All" genders, 3 trials for "Male" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "AZ Sint-Lucas". undefined are not yet recruiting, 9 are recruiting, 6 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 20 completed trials in AZ Sint-Lucas, undefined suspended trials, and 5 terminated clinical trials to date.

Out of the total trials that were conducted in AZ Sint-Lucas, 0 "Phase 1" clinical trials were conducted, 13 "Phase 2" clinical trials and 16 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 4 trials, and there were also 2 trials that are defined as “Not Applicable".